Mohs Reconstruction & Eyelid Cancer
Eyelid cancer is a broad term for cancer that occurs on or in the eyelid. There are several kinds of eyelid cancers, including:
Basal cell eyelid cancer occurs in the lower epidermis, in round cells called basal cells. About 80% of skin cancers come from this layer of the skin, which directly correlates to sun exposure.
Basal cell is the most common eyelid cancer, usually affecting the lower lid. Your basal cell eyelid cancer risk may increase if you have fair or pale skin.
Squamous Cell Carcinoma
You’ll find squamous cells in the top layer of the epidermis, with 10 to 30% of skin cancers beginning in this layer. Most squamous cell carcinomas occur due to sun exposure.
However, you may also see squamous cell carcinoma on burned skin, skin damaged by chemicals, or skin that’s received x-ray exposure. Squamous cell carcinoma behaves aggressively and can quickly spread to nearby tissues.
Sebaceous Cell Carcinoma
Sebaceous cell carcinoma is the second most common kind of eyelid cancer. It’s usually seen in middle-aged to older adults.
Sebaceous cell carcinoma is an aggressive eyelid cancer that usually affects the upper eyelid. It’s often associated with Bowen’s disease, radiation exposure, and Muir-Torre syndrome.
You may need surgical eye removal if you have a sizeable sebaceous cell carcinoma or one that returns after treatment.
Of the three skin cancer types, melanoma is the most serious. The deepest layer of the epidermis has scattered cells called melanocytes.
Melanocytes produce melanin, which helps give your skin color and pigment. Melanoma begins in the melanocytes and is more likely to spread to other body parts.
Mohs reconstructive surgery treats skin cancer affecting the lips, nose, or tissue around the eyes. With reconstructive surgery, Dr. Hayek will not only treat your cancer, but he’ll be able to rebuild your facial features to ensure you feel more comfortable with your appearance and how you look.
Mohs surgery is usually used to treat skin cancer like melanoma, basal cell carcinoma, and squamous cell carcinoma.